Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Conagra Brands Inc (CAG) - Conagra Brands has a dividend yield of 8.20% [6] - Deutsche Bank analyst Steve Powers maintained a Hold rating and reduced the price target from $19 to $18, with an accuracy rate of 66% [6] - Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating and lowered the price target from $21 to $19, with an accuracy rate of 67% [6] - Recent news indicates that Conagra Brands posted mixed quarterly results on December 19 [6] Group 2: Altria Group Inc (MO) - Altria Group has a dividend yield of 7.19% [6] - B of A Securities analyst Lisa Lewandowski maintained a Buy rating and raised the price target from $64 to $72, with an accuracy rate of 58% [6] - Barclays analyst Gaurav Jain maintained an Underweight rating and increased the price target from $49 to $57, with an accuracy rate of 57% [6] - Recent news includes the retirement of CEO Billy Gifford and the appointment of Sal Mancuso as his successor on December 11 [6] Group 3: Flowers Foods Inc (FLO) - Flowers Foods has a dividend yield of 9.11% [6] - DA Davidson analyst Brian Holland maintained a Neutral rating with a price target of $15, with an accuracy rate of 53% [6] - Jefferies analyst Rob Dickerson maintained a Hold rating and reduced the price target from $23 to $20, with an accuracy rate of 64% [6] - Recent news shows that Flowers Foods posted in-line quarterly earnings on November 6 [6]

Core Insights - Altria Group, Inc. and Philip Morris International Inc. are major players in the global tobacco industry, each with unique geographic exposure and strategic focuses [1][2] - Altria has a market capitalization of approximately $98.5 billion, primarily focused on the U.S. market, while Philip Morris has a larger market cap of about $248.6 billion, reflecting its international presence and innovation in reduced-risk products [1][2] Altria's Position - Altria maintains a strong position in the U.S. tobacco market, with a 64.4% adjusted operating companies income margin in Q3 2025, indicating strong pricing power despite declining cigarette volumes [3][6] - The company is investing in smoke-free products, with on! nicotine pouch shipments reaching 133.6 million cans year-to-date, and continues to innovate with products like on! PLUS and Horizon's Ploom [4][8] - Altria increased its quarterly dividend by 3.9% to $1.06 per share in August 2025, marking its 60th dividend increase in 56 years, and expanded its share-repurchase authorization to $2 billion through 2026 [5] - Domestic cigarette shipment volumes declined by 8.2% in Q3, and Marlboro's market share decreased by 1.2 percentage points to 40.4%, highlighting ongoing challenges [6] Philip Morris' Growth - Philip Morris is increasingly focused on smoke-free products, which accounted for 41% of total net revenues and 42% of gross profit in Q3 2025, with shipments growing by 16.6% year-over-year [7][9] - Key smoke-free brands like IQOS, ZYN, and VEEV are driving revenue growth, with IQOS leading in heated tobacco globally [9] - Operational discipline and cost controls have supported margin expansion and earnings growth, while the combustible segment remains under pressure with a 3.2% decline in cigarette shipment volumes [10][11] Earnings Estimates - The Zacks Consensus Estimate for Altria's EPS indicates a year-over-year increase of approximately 6.3% for 2025 and 2.3% for 2026, remaining unchanged at $5.44 and $5.56 respectively [12] - For Philip Morris, the consensus estimate implies year-over-year growth of 14.2% for 2025 and 11.3% for 2026, with estimates slightly down to $7.50 and $8.35 [14] Stock Performance and Valuation - Over the past year, Altria's shares have increased by 17.4%, while Philip Morris has seen a stronger gain of 33.9% [15] - Altria's forward P/E ratio is 10.54, below its one-year median of 10.80, while Philip Morris' forward P/E ratio stands at 19.17, also below its median of 20.59 [16] Investment Appeal - Philip Morris offers stronger global growth and leadership in reduced-risk products, while Altria provides a compelling value proposition with higher income visibility and resilient margins [17] - Altria is viewed as a better option for income-focused investors seeking stability and consistent returns amid the industry's transition to smoke-free products [17]

Core Insights - Altria Group, Inc. has authorized an expansion of its share repurchase program from $1 billion to $2 billion, extending the program's expiration to December 31, 2026, indicating a strong commitment to returning value to shareholders [2][9] Capital Allocation Strategy - The decision to increase the buyback program follows a period of active repurchases in 2025, where Altria repurchased 1.9 million shares at an average price of $60.13, spending $112 million in Q3 2025, and a total of 12.3 million shares for $712 million in the first nine months of 2025 [3][9] - The structure of the expanded buyback program suggests a steady approach, allowing Altria to maintain discretion over timing while reinforcing buybacks as a key component of its capital return strategy [4] Earnings and Valuation - The expanded buyback may help mitigate modest earnings per share pressure due to declining cigarette volumes, reflecting confidence in Altria's cash generation and disciplined capital allocation [5] - Altria's shares have gained 1.3% in the past month, compared to the industry's growth of 3.1%, and the company trades at a forward price-to-earnings ratio of 10.45X, lower than the industry average of 14.26X [8][11] Earnings Estimates - The Zacks Consensus Estimate for Altria's earnings implies year-over-year growth of 6.3% for 2025 and 2.3% for 2026, with current estimates for the current year at $5.44 and next year at $5.56 [12][13]

For some Americans, cigarettes are an essential product, despite the cost of smoking averaging $3,000 per smoker per year. ...

Core Points - The U.S. Food and Drug Administration (FDA) has authorized the marketing of six nicotine pouch products owned by Altria [1] - This authorization is part of a pilot program designed to expedite the review process for such products [1] Company Summary - Altria has received FDA approval for six of its nicotine pouch products, indicating a significant step in the company's product portfolio expansion [1] - The pilot program aims to streamline the regulatory process for nicotine products, potentially benefiting Altria and similar companies in the industry [1] Industry Summary - The FDA's initiative reflects a broader trend towards the regulation and acceptance of alternative nicotine delivery systems [1] - The approval of these products may influence market dynamics and competition within the nicotine pouch segment [1]

Core Insights - Altria Group, Inc. is observing significant growth in the e-vapor category, with U.S. adult usage projected to reach approximately 21 million consumers by the end of Q3 2025, primarily driven by disposable products [1][9] E-Vapor Market Dynamics - The recent growth in the e-vapor market is largely attributed to disposable e-vapor products, which have added around 2.4 million users and now represent over 60% of the category. These products are typically flavored, low-priced, and widely available, although many lack FDA authorization [2][9] - Altria's e-vapor business, centered around the NJOY brand, focuses on FDA-authorized products, which limits its participation in the segment that is driving most of the new user adoption [2] Regulatory Environment - Altria has advocated for stronger enforcement against unauthorized e-vapor products. Federal agencies have recently intensified actions against illicit e-vapor, including coordinated raids and large-scale seizures, indicating increased regulatory scrutiny in the category [3][9] Financial Performance and Valuation - Altria recorded a non-cash goodwill impairment charge of $873 million in its e-vapor business during the first nine months of 2025, reflecting the challenges faced in this segment [4] - The company's shares have increased by 1% over the past month, compared to the industry's growth of 1.6% [8] - Altria's forward price-to-earnings ratio stands at 10.57X, which is lower than the industry average of 14.19X [10] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings per share has increased by 1 cent to $5.44, while the estimate for 2026 has decreased by 1 cent to $5.56 [11]

Core Insights - Altria has a current dividend yield of 7%, significantly higher than the S&P 500 average, although it is below its five-year average of 7.7% [1][6] - The company has increased its annual dividend for 56 consecutive years, qualifying it as a Dividend King, with a target payout ratio of around 80% of adjusted earnings per share [6] Financial Metrics - Altria's annual dividend is $4.24 per share, requiring ownership of 472 shares to generate $500 in annual dividend income, equating to a total investment of approximately $27,716 at the current stock price of $58.72 [2][5] - The current market capitalization of Altria is $99 billion, with a stock price of $59.32 [5] Business Performance - Altria's business is facing challenges due to a decline in the number of U.S. adult smokers, leading to reduced volume; however, the company has managed to offset some of this decline through its pricing power [4] - Despite stagnant revenue growth, Altria has maintained a gross margin of 71.98% [6]

Core Insights - Not all high-yield investments are equally valuable, with four distinct categories identified: declining businesses, manufactured distributions, selling shares, and well-covered qualified dividend yields [1] Group 1: Investment Categories - Declining businesses represent a category of high-yield investments that may not be sustainable in the long term [1] - Manufactured distributions indicate yields that are artificially created rather than derived from genuine business performance [1] - Selling shares as a method to provide high yields can lead to dilution and long-term value erosion for investors [1] - Well-covered qualified dividend yields are considered a more stable and reliable source of income for investors [1]

Core Business and Dividend - Altria Group is recognized for its strong dividend history, boasting 56 consecutive years of dividend increases and a current yield of 7% as of December 8 [2][6] - The company has maintained a stable revenue stream despite declining smoking rates among American adults, which have dropped from approximately 42% in 1965 to just over 11% in 2022 [5][6] - Altria's pricing power has allowed it to offset declining volume, as consumers often continue purchasing preferred brands despite price increases [6][7] Financial Stability and Payout Ratios - Altria aims for a payout ratio of around 80% of its adjusted earnings per share (EPS), with recent payout ratios ranging from 70.8% to 82.9% [10] - The adjusted EPS provides a clearer picture of the company's operational earnings, indicating that the dividend is not in immediate jeopardy [9][10] - The stock is currently trading at about 10.7 times projected earnings for the next 12 months, suggesting it is undervalued compared to historical standards [11] Investment Perspective - While Altria may not offer high revenue growth, it is considered a solid option for investors seeking above-average dividend income [12] - The company is viewed as a bargain for those willing to invest despite concerns regarding the traditional cigarette business [11] - Altria's long-standing presence in the market and consistent dividend payments make it an attractive choice for income-focused investors [2][12]

Core Viewpoint - Altria Group announced the retirement of Chief Executive Billy Gifford, effective May, and appointed Chief Financial Officer Sal Mancuso as his successor [1] Company Summary - Billy Gifford will retire in May, marking a significant leadership change for Altria Group [1] - Sal Mancuso, currently the Chief Financial Officer, has been named as the new CEO [1]